INS and Alzheimer disease: A longitudinal study based on Netherlandish subjects (over 5000) aged 55 years and older without dementia at baseline was performed, the results found a higher risk of AD in people with T2D, importantly, this association was stronger in subjects with T2D who reported insulin treatment [5].